Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00878228 · ClinicalTrials.gov registry record · Phase 4
Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy
A Phase 4 study of Nausea and Vomiting, Postoperative, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT00878228 is a Phase 4 study of Nausea and Vomiting, Postoperative that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 98 participants, below the 248-participant average among 5 other Nausea and Vomiting, Postoperative trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00878228, a Phase 4 study of Nausea and Vomiting, Postoperative, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a randomized placebo controlled trial to determine whether repeated postoperative prophylactic ondansetron ("Zofran") administration will prevent postoperative and/or postdischarge nausea and vomiting in patients undergoing ambulatory hip arthroscopy. Ondansetron will be administered in the intra- and post-operative period. These individuals will be followed on postoperative days 1, 2, and 3. It is hypothesized that the incidence of postdischarge nausea and vomiting (PDNV) will be significantly decreased by postoperative prophylactic administration of multiple doses of ondansetron (Zofran).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ondansetron
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00878228
The ClinicalTrials.gov registry entry for NCT00878228 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 248-participant average among 5 other Nausea and Vomiting, Postoperative trials with a reported enrollment target (60% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nausea and Vomiting, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00878228 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00878228 about?
NCT00878228 is a clinical study titled "Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy". The study is a randomized placebo controlled trial to determine whether repeated postoperative prophylactic ondansetron ("Zofran") administration will prevent postoperative and/or postdischarge nausea and vomiting in patients undergoing ambulatory hip arthroscopy. Ondansetron will be administered in...
What is the current status of trial NCT00878228?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2009-04. Estimated completion is 2010-02.
What conditions does trial NCT00878228 study?
This clinical trial studies the following conditions: Nausea and Vomiting, Postoperative.
What interventions are being tested in trial NCT00878228?
The interventions under investigation include: Placebo (DRUG), Ondansetron (DRUG).
Who is sponsoring clinical trial NCT00878228?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00878228 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nausea and Vomiting, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dexamethasone vs Ondansetron After Cesarean Delivery
COMPLETED · Phase 4
-
ENDOblock: Bilateral Superficial Cervical Blocks With Local Wound Infiltration in Thyroid Surgery
ACTIVE NOT RECRUITING · NA
-
Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks
ACTIVE NOT RECRUITING · Phase 1
-
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
COMPLETED · Phase 3
-
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.